Now the most common disease in the middle east and what could happen if we all worked together instead of individually as countries
The most prevalent diseases in Middle Eastern countries include a mix of communicable and non-communicable diseases with significant health impacts:
Communicable Diseases
Middle East Respiratory Syndrome (MERS), a viral respiratory disease with a high fatality rate, particularly in Saudi Arabia and surrounding countries.
Infectious diseases such as cholera, dengue fever, chikungunya, poliomyelitis, diphtheria, and Crimean-Congo hemorrhagic fever have had outbreaks in the region.
Hepatitis C is highly prevalent, especially in Egypt, with infection rates exceeding 10% in some areas.
Tuberculosis, bacterial and viral pneumonias, and other respiratory infections are also common, exacerbated by factors like smoking and water-pipe use.
Non-Communicable Diseases
Cardiovascular diseases (including coronary artery disease and stroke) represent the leading cause of death, accounting for a significant proportion of mortality.
Diabetes prevalence is very high in the Middle East and North Africa (MENA) region, with a projected steep rise in cases.
Other chronic conditions include chronic lung disease, chronic kidney disease, and cancers like head and neck cancer.
-
Malaria, leishmaniasis, and arboviruses such as West Nile, dengue, Alkhurma hemorrhagic fever, Rift Valley Fever, and chikungunya are also concerns due to mosquito and sandfly vectors.
-
Emerging diseases are influenced by urbanization, climate change, humanitarian crises, and mass gatherings in the region.
In summary, the Middle East faces a dual burden of persistent infectious outbreaks along with a growing challenge from non-communicable diseases like heart disease and diabetes, making healthcare priorities complex and multifaceted.
- https://www.emro.who.int/pandemic-epidemic-diseases/information-resources/infectious-disease-outbreaks-reported-in-the-eastern-mediterranean-region-in-2020.html
- https://www.emro.who.int/pandemic-epidemic-diseases/news/emerging-infectious-disease-outbreaks-reported-in-the-eastern-mediterranean-region-in-2017.html
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7118461/
- https://academic.oup.com/eurpub/article/35/Supplement_1/i3/7951902
- https://www.worldbank.org/en/news/press-release/2013/09/04/middle-east-north-Africa-health-challenges-similar-western-countries
- https://www.healthdata.org/sites/default/files/files/infographics/Infographic_GBD_ArabWorld.pdf
- https://infomineresearch.com/what-are-the-most-common-diseases-in-the-middle-east/
- https://www.cdc.gov/mers/about/index.html
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11881527/
- https://world-heart-federation.org/where-we-work/middle-east-north-africa/
If all Middle Eastern countries worked together with the United States and other international partners, many of these diseases could indeed be significantly controlled or nearly eradicated, but it requires sustained, coordinated efforts across several dimensions.
Benefits of Cooperation
-
The US Centers for Disease Control and Prevention (CDC) already collaborates closely with Middle Eastern countries through the Middle East/North Africa (MENA) Regional Office, established in 2020. This partnership strengthens public health systems, disease surveillance, laboratory capacity, workforce training, emergency response, and outbreak containment strategies.
-
Joint efforts help quickly detect and control infectious diseases such as MERS, cholera, and others, using shared data, advanced diagnostics, and rapid response teams.
-
Coordinated vaccination campaigns, public health education, and One Health approaches targeting zoonotic diseases (transmissible from animals to humans) can reduce transmission and outbreaks.
-
Enhanced regional capacities built from such cooperation can prevent local epidemics from becoming global threats and contribute to global health security.
Challenges and Considerations
-
Public health infrastructure and capabilities vary widely across Middle Eastern countries, so cooperation must consider equitable resource distribution and capacity building.
-
Political, social, and economic complexities in the region can hamper unified efforts, but health diplomacy, such as CDC's partnerships and health-focused initiatives, is a means to bridge divides.
-
Non-communicable diseases like cardiovascular diseases and diabetes require long-term public health strategies including lifestyle changes, chronic disease management, and healthcare access—which international cooperation can support but not immediately resolve.
-
Research collaboration and funding are crucial to accelerate vaccine development (e.g., MERS vaccine candidates), diagnostics, and therapeutics that benefit the whole region and beyond.
In summary, with sustained international collaboration involving the US, Middle Eastern countries have a strong foundation and opportunity to greatly reduce both communicable and non-communicable disease burdens, though eradication depends on overcoming regional challenges, political will, and long-term investment in healthcare systems.cdc+4
- https://www.cdc.gov/global-health/countries/saudi-arabia.html
- https://www.cdc.gov/global-health/regional/middle-east-north-africa.html
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7128514/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12446616/
- https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)
- https://www.ecdc.europa.eu/en/middle-east-respiratory-syndrome-coronavirus-mers-cov-situation-update
- https://cepi.net/MERS
- https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers
- https://www.sciencedirect.com/science/article/pii/S0166354218305308
- https://healthpolicy-watch.news/un-declaration-on-noncommunicable-diseases-fails-to-get-approval-due-to-us-objections/'
Comments